The Dystrophinopathies
This article reviews the epidemiology, clinical manifestations, genetic cause, management, and new and emerging therapies for this condition.
RECENT FINDINGS
New studies have highlighted how oral corticosteroids have changed the natural history of the disease, prolonging ambulation in boys with Duchenne muscular dystrophy and reducing the risk of developing scoliosis and subsequent surgical correction, improving cardiac health, and increasing long-term survival. Additionally, recent publications have provided insights into how newer and emerging treatment options are becoming more common for this condition. With gene therapy being approved in the United States for the severe form, the dystrophinopathies represent model diseases to understand the personalization of genetic treatment.
SUMMARY
Improvement in the standardization of care and the use of oral corticosteroids have increased the life expectancy of patients with dystrophinopathy and changed the natural history of the disease. This article presents a summary of clinical features, diagnostic testing, and new and emerging treatment strategies for the dystrophinopathies.
Source: CONTINUUM: Lifelong Learning in Neurology - Category: Neurology Tags: REVIEW ARTICLES Source Type: research
More News: Back Curves | Boys | Brain | Corticosteroid Therapy | Epidemiology | Gene Therapy | Genetics | Learning | Muscular Dystrophy | Neurology | Reflex Sympathetic Dystrophy | Scoliosis | Study | Universities & Medical Training | USA Health